World's Best Scientists 2026 revealed!
Ronald F. van Vollenhoven

Ronald F. van Vollenhoven

D-Index & Metrics

Medicine

D-Index
106
Citations
67080
World Ranking
6367
National Ranking
242

Overview

Ronald F. van Vollenhoven is affiliated with the University of Amsterdam in the Netherlands. Their research primarily spans the field of Medicine, with a significant focus on Rheumatology. Within this, they have contributed extensively to subfields including Immunology, Radiology, Nuclear Medicine and Imaging, Hematology, and Genetics.

Their work covers several main research topics relevant to autoimmune and inflammatory diseases. These include:

  • Systemic Lupus Erythematosus Research
  • Rheumatoid Arthritis Research and Therapies
  • Monoclonal and Polyclonal Antibodies Research
  • Autoimmune and Inflammatory Disorders Research
  • Cytokine Signaling Pathways and Interactions
  • Atherosclerosis and Cardiovascular Diseases
  • Chronic Lymphocytic Leukemia Research

Ronald F. van Vollenhoven has contributed to a range of papers, often published in high-impact journals. Some notable recent publications include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update, 2020, published in Annals of the Rheumatic Diseases
  • 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis, 2020, Annals of the Rheumatic Diseases
  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update, 2023, Annals of the Rheumatic Diseases
  • Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis, 2020, Annals of the Rheumatic Diseases
  • 2021 DORIS definition of remission in SLE: final recommendations from an international task force, 2021, Lupus Science & Medicine

Their frequent co-authors indicate active collaborations with experts such as Kenneth Kalunian, Ian N Bruce, Michael T. Nurmohamed, Joan T. Merrill, and Eric F. Morand.

Ronald F. van Vollenhoven has published extensively in several venues, most prominently:

  • Annals of the Rheumatic Diseases
  • Lupus Science & Medicine
  • Lara D. Veeken
  • RMD Open
  • Arthritis & Rheumatology

Best Publications

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

    Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

    Ferdinand C Breedveld;Michael H Weisman;Arthur F Kavanaugh;Stanley B Cohen

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Antonis Fanouriakis;Myrto Kostopoulou;Alessia Alunno;Martin Aringer

  • A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    Richard Furie;Michelle Petri;Omid Zamani;Ricard Cervera

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.

    Paul Emery;Roy Fleischmann;Anna Filipowicz-Sosnowska;Joy Schechtman

  • Systemic lupus erythematosus.

    Arvind Kaul;Caroline Gordon;Mary K Crow;Zahi Touma

  • Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer

  • Tofacitinib or adalimumab versus placebo in rheumatoid arthritis

    Ronald F. van Vollenhoven;Roy Fleischmann;Stanley Cohen;Eun Bong Lee

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

    Cem Gabay;Paul Emery;Ronald van Vollenhoven;Ara Dikranian

  • 2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis

    Antonis Fanouriakis;Myrto Kostopoulou;Kim Cheema;Hans Joachim Anders

  • Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

    Edward Keystone;Désireé Van Der Heijde;David Mason;Robert Landewé

  • Tofacitinib versus Methotrexate in Rheumatoid Arthritis

    Eun-Bong Lee;Roy M Fleischmann;Stephen Hall;Bethanie E Wilkinson

  • 2016 update of the EULAR recommendations for the management of early arthritis

    Bernard Combe;Robert Landewe;Claire I Daien;Charlotte Hua

  • The frequency and outcome of lupus nephritis: results from an international inception cohort study

    John G. Hanly;Aidan G. O'Keeffe;Li Su;Murray B. Urowitz

  • Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Ian N Bruce;Aidan G O'Keeffe;Vernon Farewell;John G Hanly

  • Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

    X Mariette;M Matucci-Cerinic;K Pavelka;P Taylor

Frequent Co-Authors

Michelle Petri
Michelle Petri Johns Hopkins University School of Medicine
David A. Isenberg
David A. Isenberg University College London
Ian N. Bruce
Ian N. Bruce University of Manchester
Caroline Gordon
Caroline Gordon University of Birmingham
Daniel J. Wallace
Daniel J. Wallace Cedars-Sinai Medical Center
Rosalind Ramsey-Goldman
Rosalind Ramsey-Goldman Northwestern University
Cynthia Aranow
Cynthia Aranow Feinstein Institute for Medical Research
Murray B. Urowitz
Murray B. Urowitz University of Toronto
Ann E. Clarke
Ann E. Clarke University of Calgary
Susan Manzi
Susan Manzi Allegheny Health Network

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring further options in healthcare can lead to diverse and rewarding career opportunities beyond traditional medical school. For those seeking flexible entry points, programs like the lpn program no entrance exam remove many barriers to starting a nursing career, making the transition to nursing faster and more accessible.

If your interests align more with leadership and administration, pursuing a healthcare administration associate degree online is an excellent way to gain crucial management skills and qualify for roles in hospitals, clinics, or insurance companies.

Nurses with an Associate Degree in Nursing can advance to higher clinical roles through adn to fnp bridge programs, enabling them to become Family Nurse Practitioners faster and with greater flexibility.

For those interested in diet, wellness, and preventive medicine, the best online food science degree programs provide a path to careers in nutrition, research, and public health.

Each of these online degree pathways offers unique opportunities to grow in the expanding healthcare sector, whether your goal is direct patient care, management, or health promotion.

Best Scientists Citing Ronald F. van Vollenhoven

Trending Scientists

Recently Published Articles